Keshavarz AA et al. |
Omeprazole-based triple therapy with low-versus high-dose of clarithromycin plus amoxicillin for H pylori eradication in Iranian population. |
2007 |
World J. Gastroenterol. |
pmid:17352026
|
Lai YC et al. |
Density of Helicobacter pylori may affect the efficacy of eradication therapy and ulcer healing in patients with active duodenal ulcers. |
2003 |
World J. Gastroenterol. |
pmid:12854158
|
Losurdo G et al. |
Role of concomitant therapy for eradication: A technical note. |
2016 |
World J. Gastroenterol. |
pmid:27784977
|
Robles-Jara C et al. |
Is a 7-day Helicobater pylori treatment enough for eradication and inactivation of gastric inflammatory activity? |
2008 |
World J. Gastroenterol. |
pmid:18473407
|
Koussoulas V et al. |
Evidence for the role of gastric mucosa at the secretion of soluble triggering receptor expressed on myeloid cells (strem-1) in peptic ulcer disease. |
2007 |
World J. Gastroenterol. |
pmid:17729416
|
Attaran B et al. |
Effect of biofilm formation by clinical isolates of on the efflux-mediated resistance to commonly used antibiotics. |
2017 |
World J. Gastroenterol. |
pmid:28275296
|
Ching SS et al. |
Treatment of Helicobacter pylori in surgical practice: a randomised trial of triple versus quadruple therapy in a rural district general hospital. |
2008 |
World J. Gastroenterol. |
pmid:18609709
|
Iannone A et al. |
New fecal test for non-invasive detection: A diagnostic accuracy study. |
2018 |
World J. Gastroenterol. |
pmid:30038469
|
Bustamante-Rengifo JA et al. |
In vitro effect of amoxicillin and clarithromycin on the 3' region of cagA gene in Helicobacter pylori isolates. |
2013 |
World J. Gastroenterol. |
pmid:24106405
|
Lan L et al. |
Symptom-based tendencies of Helicobacter pylori eradication in patients with functional dyspepsia. |
2011 |
World J. Gastroenterol. |
pmid:21912474
|
Deng ZH et al. |
Influence of Helicobacter pylori infection on ghrelin levels in children. |
2012 |
World J. Gastroenterol. |
pmid:23049220
|
Brennan DE et al. |
Can bacterial virulence factors predict antibiotic resistant infection? |
2018 |
World J. Gastroenterol. |
pmid:29531461
|
Wang B et al. |
Standard triple therapy for Helicobacter pylori infection in China: a meta-analysis. |
2014 |
World J. Gastroenterol. |
pmid:25356059
|
Khan A et al. |
Antibiotic resistance and cagA gene correlation: a looming crisis of Helicobacter pylori. |
2012 |
World J. Gastroenterol. |
pmid:22611319
|
Cianci R et al. |
Third-line rescue therapy for Helicobacter pylori infection. |
2006 |
World J. Gastroenterol. |
pmid:16688818
|
Zhou Q et al. |
Drug utilization of clarithromycin for gastrointestinal disease treatment. |
2008 |
World J. Gastroenterol. |
pmid:18932287
|
Isomoto H et al. |
Sofalcone, a mucoprotective agent, increases the cure rate of Helicobacter pylori infection when combined with rabeprazole, amoxicillin and clarithromycin. |
2005 |
World J. Gastroenterol. |
pmid:15786539
|
Bustamante-Rengifo JA et al. |
Effect of treatment failure on the CagA EPIYA motif in strains from Colombian subjects. |
2017 |
World J. Gastroenterol. |
pmid:28373764
|
Zhao LJ et al. |
Helicobacter pylori isolates from ethnic minority patients in Guangxi: resistance rates, mechanisms, and genotype. |
2014 |
World J. Gastroenterol. |
pmid:24782630
|
Garza-González E et al. |
A review of Helicobacter pylori diagnosis, treatment, and methods to detect eradication. |
2014 |
World J. Gastroenterol. |
pmid:24587620
|